A Study of Ruxolitinib and Duvelisib in People With Lymphoma
for T-cell Lymphomas
Drug: Ruxolitinib
9 locations incl. Miami
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 18+
Code: NCT05010005·Phase 1·Recruiting
As of June 2026, 297 paid clinical trials are recruiting in Harrison, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .